Patient 9 of the Eledon trial, who received an islet cell transplant, talks about life after being "cured" of type 1 diabetes and the work still left to be done.
How to Exercise as a T1D and Maintain Your Time in Range
We break down the science behind exercising with T1D, offer ideas and strategies to help improve your time in range, and how to diabetes technology can help.
FDA Expands Tzield to Children Age 1+ to Delay Type 1 Diabetes
Sanofi's disease-modifying therapy can now be used in children as young as 1 year old, opening a new window to delay type 1 diabetes progression in the youngest patients.
Sana Biotechnology and Mayo Clinic Team Up for Potential Type 1 Diabetes Cure
The two have partnered to develop SC451, an investigational cell therapy aiming to restore the body’s ability to regulate glucose and eliminate the need for both insulin and immunosuppressive therapy.
Blue Circle Gives Free Support to Adults with Type 1 Diabetes - How it Works
Nw operating in 20 states and Washington, D.C., Blue Circle Health is expanding free, comprehensive support for adults living with type 1 diabetes across the country.
CamDiab Unveils Fully Closed-Loop Feature on CamAPS FX
The new Liberty feature allows people with type 1 diabetes to temporarily stop counting carbs or deliver boluses while CamAPS FX automatically manages glucose levels.
Essential On-the-Go Diabetes Supplies: Coolers, Travel Bags & More
Here's a list of our go-to accessories from coolers, cases, and patches, to snacks that help keep your diabetes management on track no matter where you go.
An Islet Cell Transplant Without Immunosuppression Shows Promise - We Spoke with Patient #1
Encapsulated neonatal pig islet cells, implanted without immunosuppression in the OPF-310 trial, cut a type 1 diabetes patient’s insulin needs in half at six months, with further maturation expected.
Afrezza Launches Trial to Bring Inhaled Insulin to Children With Type 1 Diabetes
MannKind’s INHALE‐1ST trial is testing an inhaled insulin, as a needle‐free option for children with type 1 diabetes with an expected FDA decision by May 29, 2026.
twiist Pump Review - Here's What I Think After 2 Months Using it
I used the twiist insulin pump for over 2 months and break down how it works day to day, iPhone and app watch control, settings and alerts and my glucose control results.
As more insulin pumps move to pharmacy benefits, switching systems is easier than ever—but it’s also exposing serious gaps in safety, training, and support.
How Secure Is Your Insulin Pump? A Cybersecurity Expert Explains
A cybersecurity expert explains the precautions behind insulin pumps, CGMs, and why managing diabetes in secure government facilities requires a different level of protection.
